首页> 外文OA文献 >Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines

【2h】

Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines

机译：TP53和抗衰老DDR1受体对旱獭/ ERK和PI3K / AKT表达和化学治疗药物敏感性的影响及抗衰老DDR1受体在前列腺癌细胞系中的表达及化疗药物敏感性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
William H. Chappell; Saverio Candido; Stephen L. Abrams; Shaw M. Akula; Linda S. Steelman; Alberto M. Martelli; Stefano Ratti; Lucio Cocco; Melchiorre Cervello; Giuseppe Montalto; Ferdinando Nicoletti; Massimo Libra; James A. McCubrey;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. NSK-01105 inhibits proliferation and induces apoptosis of prostate cancer cells by blocking the Raf/MEK/ERK and PI3K/Akt/mTOR signal pathways [J] . Yu Pengfei, Ye Liang, Wang Hongbo, Tumour biology : . 2015,第3期

机译：NSK-01105通过阻断Raf / MEK / ERK和PI3K / Akt / mTOR信号通路抑制增殖并诱导前列腺癌细胞凋亡
2. β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways [J] . Pengyu Su, Bashir Ahmad, Kun Zou, OncoTargets and therapy . 2020,第2期

机译：β-榄乙烯通过PI3K / AKT，RAF-MEK-ERK和NF-κB信号传导途径增强了5-氟尿嘧啶的化学治疗效果
3. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mT0RC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma [J] . Shaw M. Akula, Stephen L Abrams, Linda S. Steelman, Expert opinion on therapeutic targets . 2019,第7a12期

机译：RAS / RAF / MEK / ERK，PI3K / PTEN / AKT / MT0RC1和TP53路径和监管MIR作为肝细胞癌的治疗靶标
4. Role of the Androgen Receptor and PI3K/Akt in the Survival of Androgen-Refractory Prostate Cancer Cells [C] . Haojie Huang, Donald J. Tindal International Symposium on Hormonal Carcinogenesis . 2005

机译：雄激素受体和PI3K / AKT在雄激素难治性前列腺癌细胞存活中的作用
5. Targeting the MEK5, MEK1/2, and/or Pi3k Pathways Reverses Epithelial to Mesenchymal Transition and Enhances Chemotherapeutic Sensitivity in Breast and Brain Cancers with a Mesenchymal Phenotype [D] . Bhatt, Akshita B. 2021

机译：靶向MEK5，MEK1 / 2和/或PI3K途径将上皮细胞转型的上皮性反转，并通过间充质表型提高乳腺癌和脑癌中的化疗敏感性
6. Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines [O] . William H. Chappell, Saverio Candido, Stephen L. Abrams, 2020

机译：TP53和抗衰老DDR1受体对前列腺癌细胞系Raf / MEK / ERK和PI3K / Akt表达及化疗药物敏感性控制的影响
7. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging [O] . Steelman, Linda S., Chappell, William H., Abrams, Stephen L., 2011

机译：Raf / MEK / ERK和PI3K / PTEN / Akt / mTOR通路在控制生长和对癌症和衰老的治疗影响的敏感性中的作用
8. Modulation of Epidermal Growth Factor Receptor Expression by Chemotherapeutic Agents in Breast Cancer Cell Lines [R] . Welch, J. N. 2002

机译：化学治疗剂对乳腺癌细胞系中表皮生长因子受体表达的调节作用

Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines

著录项

引文网络

相似文献

相关主题

期刊订阅